Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nicotinamide adenine dinucleotide (NAD) metabolism enzymes are a group of proteins that regulate the synthesis, recycling, and consumption of NAD+, a vital coenzyme found in all living cells. These enzymes play central roles in cellular energy production, redox reactions, DNA repair, gene expression regulation, and cell signaling. Key enzymes include NAMPT, NMNAT1/2/3, NNMT, PARPs, and Sirtuins. Dysregulation is linked with aging-related decline in energy metabolism, impaired stress responses/DNA repair capacity, neurodegenerative diseases, cancer progression/metabolic disorders. Boosting or modulating activity/expression levels has therapeutic potential for age-related diseases.
Modulation of NAD+ metabolism (e.g., increasing NAD+ levels, inhibiting NAD+ consuming enzymes)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nicotinamide Adenine Dinucleotide Metabolism Enzyme (None).